'On standalone basis
Quarter ended September 2025 compared with Quarter ended September 2024.
Net sales (including other operating income) of Abbott India has increased 7.62% to Rs 1,757.15 crore. Operating profit margin has jumped from 26.89% to 28.58%, leading to 14.40% rise in operating profit to Rs 502.17 crore. Raw material cost as a % of total sales (net of stock adjustments) decreased from 10.48% to 9.47%. Purchase of finished goods cost fell from 44.99% to 42.73%. Employee cost increased from 8.98% to 9.26%. Other expenses rose from 8.81% to 9.27%.
Other income up 15.66% to Rs 69.95 crore. PBIDT rose 14.55% to Rs 572.12 crore. Provision for interest up 202% to Rs 7.55 crore. Loan funds rose to Rs 182.45 crore as of 30 September 2025 from Rs 60.50 crore as of 30 September 2024. Inventories rose to Rs 937.87 crore as of 30 September ...
Pleaselogin & subscribe to view the full report.
More Reports
-
(17-Jan-2026)
Federal Bank
Healthy all-round performance
-
(17-Jan-2026)
Fedbank Financial Services
AUM growth accelerates to 17%, spreads improve
-
(17-Jan-2026)
Tech Mahindra
NP up 14.1% YoY to Rs 1122 crore in Q3FY2026
-
(17-Jan-2026)
Wipro
Revenue up 5.5% yoy to Rs 23555.8 crore in Q3FY2026
|
|